Protagonist Therapeutics, Inc. (PTGX) Social Stream
Protagonist Therapeutics Inc (PTGX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PTGX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 41 days, PTGX's average price target has gone down $0.5.
PTGX reports an average of 96.11% for its upside potential over the past 140 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PTGX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 151 days, PTGX's average broker recommendation rating improved by 0.88.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, Protagonist Therapeutics Inc's variance in analysts' estimates is lower than -439.31% of them.
- To contextualize these metrics, consider that out of all US stocks, Protagonist Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 499.14% of them.
- In terms of how Protagonist Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 445.24% of that group.
- In the context of Pharmaceutical Products stocks, Protagonist Therapeutics Inc's number of analysts covering the stock is greater than 386.97% of them.
Is PTGX a Buy, Hold or Sell? See the POWR Ratings now!